Volume | 0 |
|
|||||
Noticias | - | ||||||
Máximo del Dia | Mínimo Máximo |
||||||
Minimo del Dia |
Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
---|---|---|---|
DMK Pharmaceuticals Corporation | DMK | NASDAQ | Acción Común |
Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
---|---|---|---|---|
0.232 | 0.232 |
Operaciones | Volume Operado de la Acción | Volumen promedio | Rango 52 semanas |
---|---|---|---|
0 | 0 | - | 0.177 - 1.50 |
Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
---|---|---|---|---|
- | 0 | US$ 0.232 | USD |
Información Financiera DMK Pharmaceuticals Corporation DMK
Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
---|---|---|---|---|---|---|
US$ 2.34M | - | - | - | -821.29 |
Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
---|---|---|---|---|---|
- | - | - | - |
Noticias sobre DMK Pharmaceuticals Corporation DMK
Fecha | Hora | Fuente | Noticias Artículo |
---|---|---|---|
21/3/2024 | 13:23 | Edgar (US Regulatory) | Form 25-NSE - Notification filed by national security.. |
07/2/2024 | 16:19 | Edgar (US Regulatory) | Form 8-K - Current report |
06/2/2024 | 09:04 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
05/2/2024 | 08:00 | Edgar (US Regulatory) | Form 8-K - Current report |
31/1/2024 | 16:17 | Edgar (US Regulatory) | Form 8-K - Current report |
23/1/2024 | 16:23 | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting.. |
23/1/2024 | 16:22 | Edgar (US Regulatory) | Form 8-K - Current report |
03/1/2024 | 16:03 | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting.. |
03/1/2024 | 16:02 | Edgar (US Regulatory) | Form 8-K - Current report |
03/1/2024 | 16:00 | Edgar (US Regulatory) | Form 8-K - Current report |
21/12/2023 | 11:31 | Edgar (US Regulatory) | Form 8-K - Current report |
21/12/2023 | 07:15 | GlobeNewswire Inc. | DMK Pharmaceuticals Regains Full Rights to Commercialize.. |
Histórico de Datos DMK
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
6 Months | 0.75 | 0.7837 | 0.177 | 0.2669055 | 1,081,041 | -0.518 | -69.07% |
1 Year | 0.7261 | 1.50 | 0.177 | 0.6419828 | 1,370,892 | -0.4941 | -68.05% |
3 Years | 0.7261 | 1.50 | 0.177 | 0.6419828 | 1,370,892 | -0.4941 | -68.05% |
5 Years | 0.7261 | 1.50 | 0.177 | 0.6419828 | 1,370,892 | -0.4941 | -68.05% |